OClawVPS.com
Faeth Therapeutics
Edit

Faeth Therapeutics

https://www.faeththerapeutics.com/
Last activity: 18.02.2026
Active
Categories: AIBiotechnologyMetabolismOncologyTherapeutics
Faeth makes personalized, precision, effective diets for cancer patients.
Website visits
12.4K /mo.
Mentions
23
Location: United States
Employees: 11-50
Total raised: $92M

Investors 7

Funding Rounds 3

DateSeriesAmountInvestors
21.10.2025-$25MKhosla Ven...
30.06.2022Series A$47MKdT Ventur...
18.01.2022Seed$20MKhosla Ven...

Mentions in press and media 23

DateTitleDescription
18.02.2026Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Solve PI3K ResistanceWhat You Should Know The Deal: Sensei Biotherapeutics has acquired Faeth Therapeutics in a stock-for-stock transaction. Concurrently, Sensei raised a massive $200M in private placement financing to fuel the combined company. The Asset: The ...
21.10.2025Faeth Therapeutics Secures $25M to Propel Cancer Metabolism TherapiesFaeth Therapeutics secured $25 million, raising its total capital to $92 million. This vital funding drives its lead PIKTOR program for endometrial cancer into Phase 2, following an impressive 80% response rate. It also expands the AI-drive...
21.10.2025Faeth Therapeutics Raises $25M in FundingCredit: Faeth Therapeutics Faeth Therapeutics, an Austin, Texas-based clinical-stage biotechnology company advancing therapies that systematically target tumor metabolism, raised $25m in funding. The financing, which brought total capital r...
20.10.2025Faeth Therapeutics: $25 Million Raised To Advance PIKTOR Phase 2 Trial Following 80% Response Rate In Endometrial CancerFaeth Therapeutics, a clinical-stage biotechnology company pioneering metabolism-based cancer therapies, announced a $25 million strategic financing round to advance its lead program, PIKTOR, in endometrial cancer. The raise brings Faeth’s ...
06.11.2023People moves: Foodpanda CEO departs amid rumors, Syngenta has a new boss, Post CEO on sudden medical leaveStay up to speed with the latest people moves in agrifood and tech with AgFunderNews’ monthly column of the industry’s biggest leadership changes. In the last month, Foodpanda’s longtime CEO departed amid a bit of drama, Syngenta Group and ...
28.07.2023Report: The 4 Challenges Facing the Food as Medicine MovementThe food as medicine movement has been picking up steam, with the White House gathering $8 billion in commitments for food programs, payers launching medically-tailored meal pilots and startups gaining funding from investors. Growing resear...
01.02.2023Who were the most active food and agriculture technology venture capital firms in 2022?Data Snapshot is a regular AFN feature in which we analyze agrifoodtech market investment data provided by our parent company, AgFunder, a food and agriculture technology venture capital firm. Click here for more research from AgFunder and ...
24.08.2022Pancreatic Cancer Patients Will Now Have Remote Access to Precision Nutrition Trial Through New PartnershipxCures and Vault Health integration creates a decentralized platform to benefit pancreatic cancer research and facilitate enrollment in Faeth’s NEAAR-001 study By enabling remote access to the NEAAR-001 study, a wider subset of patients can...
01.07.2022What the hell is going on with crypto lending?This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Chaos continues to swirl in the world of crypto lending, and BlockFi is on the chopping block. Pa...
30.06.2022Faeth Therapeutics Pulls In $47M Series A SAN FRANCISCO, CA, Faeth Therapeutics, a cancer metabolism company, today announced the closing of a $47 million Series A round of private financing. >> Click here for more funding data on Faeth Therapeutics >> To export Fae...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In